Popular Articles

LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs Of Clinical Benefit
Santaris Pharma announced that the cancer drug EZN-2968 - an inhibitor of HIF-1alpha, jointly developed by Enzon Pharmaceuticals and Santaris Pharma A/S - was well tolerated and showed early signs of clinical benefit in previously treated cancer patients with advanced malignancies. EZN-2968 is being evaluated in patients with solid tumors and lymphoma. The study data, which was presented at the 2009 American Society of Clinical Oncology (ASCO) annual meeting in Florida last week, demonstrated that EZN-2968 is well tolerated, and that early signs of clinical benefit - prolonged stable disease - were observed in several patients.
drugs without prescription
Link Between Extreme Glucose Levels In Diabetic Patients With Heart Failure And Increased Risk Of Death
Compared with patients with moderately controlled glucose levels, diabetic patients who have heart failure and either too high or too low glucose levels may be at increased risk of death, said researchers at Baylor College of Medicine in a report published in the current issue of Journal of the American College of Cardiology.
News of the day
Unseen Long-Term Benefits From Cystic Fibrosis Treatments
Cystic fibrosis medicines that help to break down mucus in the lungs may carry an unexpected long-term benefit, a study suggests.
Oncology

Confirmation Hearings For Supreme Court Nominee Sotomayor To Begin July 13

Senate Democrats on Tuesday announced that confirmation hearings for Judge Sonia Sotomayor"s nomination to the Supreme Court are set to begin on July 13, the New York Times reports. According to Democrats, the schedule puts the Senate on track to confirm Sotomayor before the August recess. By the Thursday before the recess, 72 days will have elapsed since President Obama nominated Sotomayor, which is the same number of days that passed during the confirmation process for Chief Justice John Roberts (Herszenhorn, New York Times, 6/10).Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) said, "There is no reason to unduly delay consideration of this well-qualified nominee." He said that critics" attacks on her character are "compelling reasons to proceed even ahead of this schedule," adding that Sotomayor needs to be given a chance to respond to her critics (Isenstadt/Raju, Politico, 6/9).Republican senators have started a campaign to stall the confirmation process, saying they need more time to review her judicial record (LoBianco, Washington Times, 6/10). Republican senators had requested to delay the hearing until September. Senate Minority Leader Mitch McConnell (R-Ky.) said that Democrats are acting "unilaterally" and "being dismissive of the minority"s legitimate concerns for a fair and thorough process."Senate Majority Leader Harry Reid (D-Nev.) said he discussed the timeline with Obama and Leahy, both of whom had reviewed a letter from McConnell that expressed concerns about the process starting before September. According to Reid, Obama and Leahy went ahead with an earlier schedule after concluding that the timetable was similar to that of past nominations (New York Times, 6/10). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):